Research ArticleOncology
Open Access
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis and Freddy E. Escorcia
Journal of Nuclear Medicine March 2021, 62 (3) 366-371; DOI: https://doi.org/10.2967/jnumed.120.244897
Patricia M.R. Pereira
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Jalen Norfleet
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Jason S. Lewis
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Molecular Pharmacology Program and Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, and Departments of Pharmacology and Radiology, Weill Cornell Medical College, New York, New York; and
Freddy E. Escorcia
3Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis, Freddy E. Escorcia
Journal of Nuclear Medicine Mar 2021, 62 (3) 366-371; DOI: 10.2967/jnumed.120.244897
Jump to section
Related Articles
Cited By...
- No citing articles found.